基因靶向治疗肝癌的新进展

发布时间：2018-05-18 22:09

本文选题：原发性肝癌 + 基因治疗　；参考：《检验医学与临床》2016年10期

【摘要】：正原发性肝癌是消化道最常见的恶性肿瘤之一,是世界范围内男性第2位、女性第6位的癌症死亡原因,肝癌已严重威胁到人们正常的生活~([1])。目前,肝脏手术切除与肝移植是治疗肝癌比较有效的方法,但大多数患者就诊时已是晚期,失去最佳手术和肝移植机会,因此探索新的治疗方法是当前肝癌治疗研究的热点。随着科技和医学的进步和发展,现已明确肝癌的发
[Abstract]:Positive primary liver cancer (PHC) is one of the most common malignant tumors in the digestive tract. It is the second leading cause of cancer death in males and the 6th leading cause of death in females. At present, hepatectomy and liver transplantation are more effective methods in the treatment of liver cancer, but most of the patients are in late stage and lose the best opportunity of operation and liver transplantation. Therefore, exploring new treatment methods is a hot spot in the current research of liver cancer treatment. With the progress and development of science and technology and medicine, the development of liver cancer has been clarified.
【作者单位】：重庆医科大学附属第二医院放射科;
【基金】：重庆市卫生局重点项目(2013-1-021)
【分类号】：R735.7

【相似文献】